Middle East and Africa Cell-based Assays Market - Industry Trends and Forecast to 2026
- DAT3297517
- 80 Pages
- September 2019
- Healthcare
Market Segmentation:
By Type (Cell Viability Assay, Cytotoxicity Assay, Cell Death Assay, Cell Proliferation Assay, Others), Product & Services (Consumables, Services, Instruments and Software), Technology (Flow Cytometry, High Throughput Screening, High Content Screening, Label Free Detection), Application (Drug Discovery, Basic Research, Others), End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic & Research Institutions, Government Organizations, Others), Distribution Channel (Direct, Indirect), Country (South Africa, Rest of Middle East and Africa)
Some of the major factors contributing to the growth of the market:
• Rising demands for novel small drug and major therapeutics in MEA regions
• Government funding in research and development areas for major diseases in MEA regions
• Increasing incidence of Cancer, Rheumatoid arthritis and many other chronic diseases.
Market Players:
The key market players for Middle East and Africa cell based assays market are listed below:
• GENERAL ELECTRIC
• Danaher
• Agilent Technologies, Inc.
• Thermo Fisher Scientific Inc.
• Merck KGaA
• PerkinElmer Inc.
• Bio-Rad Laboratories, Inc.
• ATCC
• Aurelia Bioscience Ltd
• BD
• BioAgilytix Labs
• BioVision Inc.
• Cell Signaling Technology, Inc
• Cisbio
• Enzo Biochem Inc
• Eurofins Scientific
• LakePharma, Inc
• Lonza
• Miltenyi Biotec
• XenoDiagnostics, LLC
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET: GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 DBMR MARKET POSITION GRID (ON THE BASIS OF PRODUCTS)
2.8 DBMR MARKET POSITION GRID
2.9 DBMR VENDOR SHARE ANALYSIS
2.10 MULTIVARIATE MODELING
2.11 PRODUCTS LIFELINE CURVE
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 INCREASING INCIDENCE OF CHRONIC DISEASES
3.1.2 RISING DEMANDS FOR NOVEL SMALL MOLECULES, BIO-THERAPEUTIC AND CELL BASED THERAPIES
3.1.3 INCREASE IN RESEARCH AND DEVELOPMENT EXPENDITURE
3.2 RESTRAINT
3.2.1 STRINGENT REGULATORY REQUIREMENTS
3.2.2 HIGH COST OF INSTRUMENTATION
3.3 OPPORTUNITIES
3.3.1 TECHNOLOGICAL ADVANCEMENTS
3.3.2 STRATEGIC INITIATIVE BY THE MARKET PLAYERS
3.4 CHALLENGES
3.4.1 CHALLENGING ANALYSIS PROCEDURE
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 MIDDLE EAST AND AFRICA CELL-BASED ASSAYS MARKET, BY TYPE
6.1 OVERVIEW
6.2 CELL VIABILITY ASSAY
6.3 CYTOTOXICITY ASSAY
6.4 CELL PROLIFERATION ASSAY
6.5 CELL DEATH ASSAY
6.6 OTHERS
7 MIDDLE EAST AND AFRICA CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICES
7.1 OVERVIEW
7.2 CONSUMABLES
7.2.1 ASSAY KITS
7.2.2 CELL LINES
7.2.2.1 PRIMARY CELL LINES
7.2.2.2 STEM CELL LINES
7.2.2.3 IMMORTALIZED CELL LINES
7.2.3 REAGENTS
7.2.4 MICROPLATES
7.3 SERVICES
7.4 INSTRUMENTS AND SOFTWARE
8 MIDDLE EAST AND AFRICA CELL-BASED ASSAYS MARKET, BY TECHNOLOGY
8.1 OVERVIEW
8.2 HIGH THROUGHPUT SCREENING
8.3 FLOW CYTOMETRY
8.4 HIGH CONTENT SCREENING
8.5 LABEL FREE DETECTION
9 MIDDLE EAST AND AFRICA CELL-BASED ASSAYS MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 DRUG DISCOVERY
9.2.1 PREDICTIVE TOXICOLOGY
9.2.2 PHARMACODYNAMIC STUDIES
9.2.3 ADME RESEARCH
9.3 BASIC RESEARCH
9.4 OTHERS
10 MIDDLE EAST AND AFRICA CELL-BASED ASSAYS MARKET, BY END USER
10.1 OVERVIEW
10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.3 CONTRACT RESEARCH ORGANIZATIONS
10.4 ACADEMIC & RESEARCH INSTITUTIONS
10.5 GOVERNMENT ORGANIZATIONS
10.6 OTHERS
11 MIDDLE EAST AND AFRICA CELL-BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT
11.3 INDIRECT
12 MIDDLE EAST AND AFRICA CELL BASED ASSAY MARKET, BY GEOGRAPHY
12.1 MIDDLE EAST AND AFRICA
12.1.1 SOUTH AFRICA
12.1.2 REST OF MIDDLE EAST AND AFRICA
12.1.3 EGYPT
12.1.4 SAUDI ARAIA
12.1.5 UNITED ARAB EMIRATES
12.1.6 ISRAEL
13 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET FOR PRODUCTS, COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
14 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET FOR SERVICES, COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
15 COMPANY PROFILE
15.1 GENERAL ELECTRIC
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENTS
15.2 DANAHER
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENT
15.3 AGILENT TECHNOLOGIES, INC.
15.3.1.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT DEVELOPMENTS
15.4 THERMO FISHER SCIENTIFIC INC
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENT
15.5 MERCK KGAA
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 PRODUCT PORTFOLIO
15.5.4 RECENT DEVELOPMENT
15.6 PERKINELMER INC, INC.
15.6.1 COMPANY SNAPSHOT
15.6.2 REVENUE ANALYSIS
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT DEVELOPMENT
15.7 BIO-RAD LABORATORIES, INC.
15.7.1 COMPANY SNAPSHOT
15.7.2 REVENUE ANALYSIS
15.7.3 PRODUCT PORTFOLIO
15.7.4 RECENT DEVELOPMENTS
15.8 ATCC
15.8.1 COMPANY SNAPSHOT
15.8.2 PRODUCT PORTFOLIO
15.8.3 RECENT DEVELOPMENT
15.9 AURELIA BIOSCIENCE LTD.
15.9.1 COMPANY SNAPSHOT
15.9.2 SERVICE PORTFOLIO
15.9.3 RECENT DEVELOPMENT
15.10 BD
15.10.1 COMPANY SNAPSHOT
15.10.2 REVENUE ANALYSIS
15.10.3 PRODUCT PORTFOLIO
15.10.4 RECENT DEVELOPMENTS
15.11 BIOAGILYTIX LABS
15.11.1 COMPANY SNAPSHOT
15.11.2 SERVICE PORTFOLIO
15.11.3 RECENT DEVELOPMENTS
15.12 BIOVISION INC.
15.12.1 COMPANY SNAPSHOT
15.12.2 PRODUCT PORTFOLIO
15.12.3 RECENT DEVELOPMENT
15.13 CELL SIGNALING TECHNOLOGY, INC.
15.13.1 COMPANY SNAPSHOT
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT DEVELOPMENT
15.14 CISBIO
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENT
15.15 ENZO BIOCHEM INC.
15.15.1 COMPANY SNAPSHOT
15.15.2 REVENUE ANALYSIS
15.15.3 PRODUCT PORTFOLIO
15.15.4 RECENT DEVELOPMENT
15.16 EUROFINS SCIENTIFIC
15.16.1 COMPANY SNAPSHOT
15.16.2 REVENUE ANALYSIS
15.16.3 PRODUCT AND SERVICE PORTFOLIO
15.16.4 RECENT DEVELOPMENTS
15.17 LAKEPHARMA, INC.
15.17.1 COMPANY SNAPSHOT
15.17.2 SERVICE PORTFOLIO
15.17.3 RECENT DEVELOPMENT
15.18 LONZA
15.18.1 COMPANY SNAPSHOT
15.18.2 REVENUE ANALYSIS
15.18.3 SERVICE PORTFOLIO
15.18.4 RECENT DEVELOPMENT
15.19 MILTENYI BIOTEC
15.19.1 COMPANY SNAPSHOT
15.19.2.2 PRODUCT PORTFOLIO
15.19.3 RECENT DEVELOPMENT
15.20 XENO DIAGNOSTICS, LLC.
15.20.1 COMPANY SNAPSHOT
15.20.2 PRODUCT PORTFOLIO
15.20.3 RECENT DEVELOPMENT
16 QUESTIONNAIRE
17 RELATED REPORTS
UU
TABLE 1 AGEING WORLD POPULATION (IN MILLIONS)
TABLE 2 TABLE REGIONS BY DIABETES PREVALENCE (%) IN ELDERLY POPULATION IN 2017 AND 2045 (IN MILLIONS)
TABLE 3 TOP 20 PHARMA COMPANIES BY SIZE OF PIPELINE
TABLE 4 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 5 MIDDLE EAST AND AFRICA CELL VIABILITY ASSAY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 6 MIDDLE EAST AND AFRICA CYTOTOXICITY ASSAY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 7 MIDDLE EAST AND AFRICA CELL PROLIFERATION ASSAY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 8 MIDDLE EAST AND AFRICA CELL DEATH ASSAY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 9 MIDDLE EAST AND AFRICA OTHERS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 10 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
TABLE 11 MIDDLE EAST AND AFRICA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 12 MIDDLE EAST AND AFRICA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
TABLE 13 MIDDLE EAST AND AFRICA CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
TABLE 14 MIDDLE EAST AND AFRICA SERVICES IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 15 MIDDLE EAST AND AFRICA INSTRUMENTS AND SOFTWARE IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 16 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
TABLE 17 MIDDLE EAST AND AFRICA HIGH THROUGHPUT SCREENING IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 18 MIDDLE EAST AND AFRICA FLOW CYTOMETRY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 19 MIDDLE EAST AND AFRICA HIGH CONTENT SCREENING IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 20 MIDDLE EAST AND AFRICA LABEL FREE DETECTION IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 21 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
TABLE 22 MIDDLE EAST AND AFRICA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 23 MIDDLE EAST AND AFRICA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
TABLE 24 MIDDLE EAST AND AFRICA BASIC RESEARCH IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 25 MIDDLE EAST AND AFRICA OTHERS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 26 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 27 MIDDLE EAST AND AFRICA PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 28 MIDDLE EAST AND AFRICA CONTRACT RESEARCH ORGANIZATIONS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 29 MIDDLE EAST AND AFRICA ACADEMIC & RESEARCH INSTITUTIONS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 30 MIDDLE EAST AND AFRICA GOVERNMENT ORGANIZATIONS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 31 MIDDLE EAST AND AFRICA OTHERS IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 32 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 33 MIDDLE EAST AND AFRICA DIRECT IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 34 MIDDLE EAST AND AFRICA INDIRECT IN CELL BASED ASSAYS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 35 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
TABLE 36 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 37 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
TABLE 38 MIDDLE EAST AND AFRICA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
TABLE 39 MIDDLE EAST AND AFRICA CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
TABLE 40 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
TABLE 41 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
TABLE 42 MIDDLE EAST AND AFRICA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
TABLE 43 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 44 MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 45 SOUTH AFRICA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
TABLE 46 SOUTH AFRICA CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
TABLE 47 SOUTH AFRICA CONSUMABLES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
TABLE 48 SOUTH AFRICA CELL LINES IN CELL BASED ASSAYS MARKET, BY PRODUCT & SERVICES, 2017-2026 (USD MILLION)
TABLE 49 SOUTH AFRICA CELL BASED ASSAYS MARKET, BY TECHNOLOGY, 2017-2026 (USD MILLION)
TABLE 50 SOUTH AFRICA CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
TABLE 51 SOUTH AFRICA DRUG DISCOVERY IN CELL BASED ASSAYS MARKET, BY APPLICATION, 2017-2026 (USD MILLION)
TABLE 52 SOUTH AFRICA CELL BASED ASSAYS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 53 SOUTH AFRICA CELL BASED ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)
TABLE 54 REST OF MIDDLE EAST AND AFRICA CELL BASED ASSAYS MARKET, BY TYPE, 2017-2026 (USD MILLION)
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
